• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany bet

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Aug 8;S1201-9712(21)00642-1.
doi: 10.1016/j.ijid.2021.08.010. Online ahead of print.
Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021


Louis Jacob[SUP] 1 [/SUP], Ai Koyanagi[SUP] 2 [/SUP], Lee Smith[SUP] 3 [/SUP], Josep Maria Haro[SUP] 4 [/SUP], Anna M Rohe[SUP] 5 [/SUP], Karel Kostev[SUP] 6 [/SUP]



Affiliations

Abstract

Aims: This study aimed to investigate the prevalence of and the factors associated with the diagnosis of coronavirus disease 2019 (COVID-19) in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
Methods: Symptomatic patients tested for COVID-19 and followed in one of 962 general practices in Germany in March 2020-March 2021 were included in this study. Covariates included sex, age and comorbidities present in at least 3% of the population. The association between these factors and the diagnosis of COVID-19 was analyzed using an adjusted logistic regression model.
Results: A total of 301,290 patients tested for COVID-19 were included in this study (54.7% women; mean [SD] age 44.6 [18.5] years). The prevalence of COVID-19 was 13.8% in this sample. Male sex and older age were positively and significantly associated with COVID-19. In terms of comorbidities, the strongest positive associations with COVID-19 were observed for cardiac arrhythmias, depression and obesity. There was also a negative relationship between the odds of being diagnosed with COVID-19 and several conditions such as chronic sinusitis, asthma and anxiety disorders.
Conclusions: Approximately 14% of symptomatic patients tested for COVID-19 were diagnosed with COVID-19 in German general practices in March 2020-March 2021.

Keywords: COVID-19 diagnosis; Germany; associated factors; general practices; prevalence; symptomatic patients.
 
Back
Top Bottom